This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the NanoKnife System (AngioDynamics Inc.) for treatment of localized prostate cancer.
Publications
Hayes Publications are available through the Hayes Knowledge Center, a portal to world-class research and unbiased analyses on the clinical, financial, and risk impacts of emerging, controversial, and disruptive healthcare technologies.Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.
See below for some of our recent publications.
Pariglasgene Brecaparvovec (Ultragenyx Pharmaceutical Inc.) for Glycogen Storage Disease Type Ia
An investigational, intravenously administered gene therapy for glycogen storage disease type Ia.
Midomafetamine (MDMA; Lykos Therapeutics) for Posttraumatic Stress Disorder
Midomafetamine (MDMA; also 3,4-methylenedioxymethamphetamine; Lykos Therapeutics) is an oral synthetic entactogen under investigation in combination with psychological intervention for the treatment of adults with posttraumatic stress disorder (PTSD).
Nemolizumab-ilto (Nemluvio; Galderma) for Prurigo Nodularis
Nemolizumab-ilto (Nemluvio; Galderma) is a subcutaneously injected interleukin-31 receptor antagonist indicated for the treatment of adults with prurigo nodularis.
Capsular Plication for Treatment of Hip Microinstability
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of capsular plication for treatment of hip microinstability.
Evoque Tricuspid Valve Replacement System (Edwards Lifesciences Corp.) for Tricuspid Regurgitation
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Evoque Tricuspid Valve Replacement System (Edwards Lifesciences Corp.) to treat patients with severe (or greater) tricuspid regurgitation (TR) despite optimal medical therapy who are not candidates for transcatheter repa…
ROMTech PortableConnect System (ROM Technologies Inc.) for Telerehabilitation Following Total Knee Arthroplasty
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of ROMTech PortableConnect system (ROM Technologies Inc.) for in-home telerehabilitation following total knee arthroplasty (TKA) for improved knee function and reduced pain.
The SetPoint System (SetPoint Medical) for Rheumatoid Arthritis
The SetPoint System is an investigational implanted vagus nerve stimulation (VNS) device being developed for treatment of rheumatoid arthritis (RA).
ProSense System (IceCure Medical) for Low-Risk Early-Stage Breast Cancer
The ProSense system (IceCure Medical) is a minimally-invasive, imaging-guided, cryoablation system proposed for treatment of low-risk early-stage breast cancer in patients who are not suitable candidates for surgical alternatives.
AB-1002 (Asklepios and Bayer) Gene Therapy for Heart Failure
AB-1002 (Bayer AG) is an investigational one-time gene therapy administered via intracoronary artery infusion to reduce symptoms of advanced nonischemic heart failure.